A study published in July 2014 by The Adelson Center for the Biology of Addictive Diseases and The Mauerberger Chair in Neuropharmacology, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel found that doses of THC low enough to not cause psychotropic activity were enough to protect mice brains from long term damage. In this study, mice were treated with a chemical that causes inflammation in the brain (lipopolysccharide, or “LPS”). Mice that received a single ultralow dose of THC either 48 hours before the LPS treatment or 1-7 days after LPS treatment, and given an object recognition test a few weeks later. LPS causes long-lasting cognitive damage, but the mice who had been treated with THC did not show that damage. Read the full study here.
For regulatory bill, two steps forward, one step back
Sen. Lou Correa’s regulatory bill, SB 1262, continued to advance through the Assembly when the Committee on Public Safety passed the bill on a vote of 6-1 late in June. The bill will next be considered by the Assembly Appropriations Committee in mid-August. Should it pass Appropriations, the bill will have a short deadline before the clock runs out — requiring a vote on the Assembly floor, followed by a concurrence vote in the Senate.
Sen. Correa’s bill would establish a regulatory framework for businesses similar to the majority of medical cannabis states. The bill has been revised many times since its introduction in February, and for the most part those changes have been positive. What was once an unworkable, harmful bill is now much more practical, but it has been flawed since the beginning. Most recently, Assembly Member Tom Ammiano contributed many big improvements, but the bill took a step back when it was amended due to intense lobbying efforts by the League of California Cities and the California Police Chiefs Association. Changes were introduced that increased licensing fees, banned collectives from accepting medical marijuana donations from members, and law enforcement was granted sweeping authority to deny business licenses under vague circumstances. For a detailed look at MPP’s position on the bill, click here.
These and other troubling provisions are now the subject of intense negotiations, and it is too early to know if they will remain in the bill. If you haven’t done so already,please ask your Assembly member to help improve the bill before it is heard by the Appropriations Committee. And you can sign up for MPP’s free email alerts on California to receive updates on marijuana policy reform efforts in the state.
(source: http://www.mpp.org/states/california/ )